Published in N Engl J Med on August 22, 1996
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care (2005) 3.96
Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2006) 3.33
Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition. Genome Biol (2007) 3.10
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med (2006) 2.99
Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis (1999) 2.96
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2009) 2.80
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43
Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A (2004) 2.32
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Invasive group A streptococcal infections. N Engl J Med (1996) 2.16
Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis (2008) 2.14
Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis (2009) 2.09
Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody. Cell Host Microbe (2011) 2.03
Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol (2004) 2.00
Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol (2005) 1.90
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci U S A (1998) 1.85
Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2008) 1.81
Necrotizing fasciitis in children in eastern Ontario: a case-control study. CMAJ (2000) 1.69
A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J (2006) 1.69
Varicella vaccination--a critical review of the evidence. Arch Dis Child (2001) 1.52
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51
Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol (2005) 1.50
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A (2010) 1.47
Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis (2012) 1.44
Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun (1999) 1.36
Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun (2003) 1.34
Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol (2003) 1.34
Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics. Can Fam Physician (2000) 1.32
Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect Immun (2002) 1.32
Purulent pericarditis caused by group a streptococcus. Tex Heart Inst J (2006) 1.31
A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest (2009) 1.30
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice. J Clin Invest (2011) 1.28
Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol (2005) 1.26
Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol (2003) 1.23
Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence (2011) 1.23
Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev (2014) 1.21
Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun (2005) 1.20
Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis (2010) 1.15
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Inhibition of cell surface export of group A streptococcal anchorless surface dehydrogenase affects bacterial adherence and antiphagocytic properties. Infect Immun (2005) 1.14
Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Crit Care (2004) 1.14
High burden of invasive beta-haemolytic streptococcal infections in Fiji. Epidemiol Infect (2007) 1.12
Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci U S A (2006) 1.09
Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis (2004) 1.09
Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol (2005) 1.06
Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis (2003) 1.06
High-resolution genotyping of Streptococcus pyogenes serotype M1 isolates by fluorescent amplified-fragment length polymorphism analysis. J Clin Microbiol (1999) 1.02
Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerg Infect Dis (2005) 1.02
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol (2011) 1.02
Invasive group a streptococcal infections, Israel. Emerg Infect Dis (2002) 1.02
Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerg Microbes Infect (2012) 1.01
Group A Streptococcal Sepsis. Curr Infect Dis Rep (2003) 1.00
Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator. PLoS One (2008) 0.99
The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis. Crit Care (2011) 0.99
Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis (2005) 0.97
Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J (2009) 0.97
Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun (2000) 0.95
High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada. J Clin Microbiol (2015) 0.95
Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India. J Clin Microbiol (2012) 0.94
Invasive group A streptococcal infections. Paediatr Child Health (1999) 0.94
Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol (2005) 0.93
Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun (2005) 0.93
Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study. Can J Infect Dis (1997) 0.93
Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol (2006) 0.92
Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high. Can Fam Physician (2000) 0.91
Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease. Indian J Crit Care Med (2012) 0.91
Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun (2007) 0.90
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis (2011) 0.89
Varicella: to vaccinate or not to vaccinate? Arch Dis Child (1998) 0.87
Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Infect Immun (1998) 0.87
Necrotising fasciitis. BMJ Case Rep (2013) 0.86
Diagnosis of group A streptococcal necrotizing fasciitis by using PCR to amplify the streptococcal pyrogenic exotoxin B gene. J Clin Microbiol (1998) 0.86
Structure and kinetic investigation of Streptococcus pyogenes family GH38 alpha-mannosidase. PLoS One (2010) 0.86
Towards universal childhood immunization against chickenpox? Paediatr Child Health (2000) 0.85
Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother (2005) 0.85
Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections. Nat Commun (2012) 0.84
Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis. Can J Infect Dis (2001) 0.84
Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis (2007) 0.84
Therapeutic Approaches to Streptococcal Toxic Shock Syndrome. Curr Infect Dis Rep (1999) 0.83
Streptococcus pyogenes bacteraemia, emm types and superantigen profiles. Eur J Clin Microbiol Infect Dis (2011) 0.82
Serotype M3 and M28 Group A Streptococci Have Distinct Capacities to Evade Neutrophil and TNF-α Responses and to Invade Soft Tissues. PLoS One (2015) 0.82
Population-based surveillance of invasive group A streptococcal disease in British Columbia: 1996 to 1998. Can J Infect Dis (2001) 0.80
The Treatment of Severe Group A Streptococcal Infections. Curr Infect Dis Rep (2003) 0.80
Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis (2003) 0.80
Preferences for health outcomes associated with Group A Streptococcal disease and vaccination. Health Qual Life Outcomes (2010) 0.80
Invasive group a streptococcal disease in nursing homes, Minnesota, 1995-2006. Emerg Infect Dis (2008) 0.79
Allelic replacement of the streptococcal cysteine protease SpeB in a Δsrv mutant background restores biofilm formation. BMC Res Notes (2010) 0.79
On the trail of necrotizing fasciitis in children. CMAJ (2001) 0.79
Flesh-eating disease: A note on necrotizing fasciitis. Can J Infect Dis (2001) 0.78
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med (1992) 6.29
The maintenance of key pecking by stimulus-contingent and response-independent food presentation. J Exp Anal Behav (1973) 6.12
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Submarine thermal sprirngs on the galapagos rift. Science (1979) 5.18
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Two different kinds of key peck in the pigeon: some properties of responses maintained by negative and positive response-reinforcer contingencies. J Exp Anal Behav (1972) 3.57
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
The role of the response-reinforcer contingency in negative automaintenance. J Exp Anal Behav (1972) 3.52
A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ (1998) 3.46
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician (1997) 3.29
Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA (1998) 3.28
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.19
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
Effects of reinforcement magnitude on pigeons' preference for different fixed-ratio schedules of reinforcement. J Exp Anal Behav (1969) 3.04
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ (2001) 2.99
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Development of complex, stereotyped behavior in pigeons. J Exp Anal Behav (1980) 2.85
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Evaluation of new medium, oxacillin resistance screening agar base, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J Clin Microbiol (2001) 2.64
The social psychology of the gift. AJS (1967) 2.63
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol (1997) 2.55
Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med (1993) 2.53
Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer (2005) 2.49
Discriminative stimulus location as a determinant of positive and negative behavioral contrast in the pigeon. J Exp Anal Behav (1975) 2.47
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Maintenance of key pecking by response-independent food presentation: the role of the modality of the signal for food. J Exp Anal Behav (1973) 2.42
Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol (2000) 2.39
Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics (1999) 2.34
Photogrammetric measurement of nerve fiber layer thickness. Ophthalmology (1989) 2.34
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Discrete-trials spaced responding in the pigeon: the dependence of efficient performance on the availability of a stimulus for collateral pecking. J Exp Anal Behav (1971) 2.31
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother (2000) 2.22
Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol (2002) 2.19
Behavioral contrast in the pigeon: a study of the duration of key pecking maintained on multiple schedules of reinforcement. J Exp Anal Behav (1975) 2.19
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis (1994) 2.09
Prostaglandins. Annu Rev Biochem (1975) 2.09
Problems with rapid agglutination methods for identification of Staphylococcus aureus when Staphylococcus saprophyticus is being tested. J Clin Microbiol (1988) 2.09
Failure to produce response variability with reinforcement. J Exp Anal Behav (1982) 2.07
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
Bacterial meningitis in children and adults. Changes in community-acquired disease may affect patient care. Postgrad Med (1998) 2.00
Identifying sick children requiring referral to hospital in Bangladesh. Bull World Health Organ (1997) 2.00
Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J (1995) 2.00